Gossamer Bio, Inc. Common Stock
$10.73
-$1.21 (-10.13%)
$10.67Day Range$12.49
Key Statistics
Market Cap
$73.03M
Shares Outstanding
6.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 8, 2019
Round Lot
100
Locale
US
Trading Data
Day Open
$12.00
Day High
$12.49
Day Low
$10.67
Volume
530.2K
VWAP
$11.21
Prev Close
$11.94
Transactions
--
Acc. Volume
--
About Gossamer Bio, Inc. Common Stock
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
PHARMACEUTICAL PREPARATIONSSIC 2834162 employees3115 MERRYFIELD ROW, SAN DIEGO, CA, 92121(858) 684-1300IPO Feb 8, 2019US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001728117
- Composite FIGI
- BBG00MVWLLM2
- Share Class FIGI
- BBG00MVWLMC1
- Ticker Root
- GOSS
- SIC Code
- 2834
About Gossamer Bio, Inc. Common Stock (GOSS) Stock
Gossamer Bio, Inc. Common Stock (GOSS) closed the 2026-09-18 session at $10.73, down 10.13% versus the previous close (-1.21). The stock opened at $12.00 and traded between $10.67 and $12.49 during that session. Session trading volume was 530K shares. The volume-weighted average price (VWAP) is $11.21.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Gossamer Bio, Inc. Common Stock has a market capitalization of $73.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. GOSS is listed on the XNAS exchange. The company employs approximately 162 people. Gossamer Bio, Inc. Common Stock is headquartered in SAN DIEGO, CA. The recorded listing date is 2019-02-08.
On this page you can find market GOSS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.